Danielle Elyse Antin-Ozerkis MD

Associate Professor of Medicine (Pulmonary)

Research Interests

Connective tissue disease/autoimmune disease associated interstitial lung disease; Genetics of interstitial lung diseases; Lung transplantation

Selected Publications

  • A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA; The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet). Am J Respir Crit Care Med. 2012 May 3. (Investigator)
  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomized trials. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group. Lancet. 2011 May 21;377(9779):1760-9. Epub 2011 May 13. (Investigator)
  • Antin-Ozerkis D and Gulati M. Cryptogenic Organizing Pneumonia. Clinical Decision Support in Medicine. 2012 In Press
  • Antin-Ozerkis D, Rubinowitz A, Evans J, Homer RJ, and Matthay RA. Connective Tissue Disease-Associated Interstitial Lung Disease. Clinics in Chest Medicine, 33(1): 123-49, March 2012.
  • Oliva I, Antin-Ozerkis D, Rubinowitz A. Imaging and Differential Diagnosis of Cystic Lung Disease. PCCSU Volume 25, Lesson 23, January 2012
  • Antin-Ozerkis D, Evans J, Rubinowitz A, Homer RJ, and Matthay RA. Pulmonary Manifestations of Rheumatoid Arthritis. Clinics in Chest Medicine, 31(3):451-78, September 2010.
  • Susan K. Mathai SK, Gulati M, Peng X, Russell T, Shaw A, Rubinowitz A, Murray LA, Siner J, Antin-Ozerkis D, Reilkoff R, Bucala R and Herzog EL. Circulating Monocytes from Systemic Sclerosis Patients with Interstitial Lung Disease Show an Enhanced Profibrotic Phenotype. Laboratory Investigation. April 19, 2010. PMID: 20404807

Edit Profile